Ceredex Value Advisors LLC Purchases New Shares in Merck & Co., Inc. $MRK

NodeGuardian · 2026-03-10T13:42:36+00:00

Ceredex Value Advisors LLC acquired 307,732 shares of Merck & Co. worth about $25.83 million. Institutional investors own 76.07% of the stock. Merck reported strong financial results, exceeding EPS and revenue expectations, and declared a $0.85 quarterly dividend.

NodeGuardian

2026-03-10 13:42:36

Abstract generation in progress

Ceredex Value Advisors LLC recently purchased 307,732 new shares of Merck & Co., Inc. (NYSE:MRK) valued at approximately $25.83 million during the third quarter. Other institutional investors also adjusted their holdings, with 76.07% of the stock owned by institutional investors and hedge funds. Merck reported strong financial results, beating analyst expectations for EPS and revenue, and announced a quarterly dividend of $0.85 per share.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes